 |
selumetinib |
|---|---|
| Trade Name | |
| Orphan Indication | Uveal melanoma |
| USA Market Approval | USA |
| USA Designation Date | 2015-04-15 00:00:00 |
| Sponsor | AstraZeneca Pharmaceuticals LP;1800 Concord Pike, P. O. Box 8355;Wilmington, Delaware, 19803 |
| |
selumetinib |
|---|---|
| Trade Name | |
| Orphan Indication | Uveal melanoma |
| USA Market Approval | USA |
| USA Designation Date | 2015-04-15 00:00:00 |
| Sponsor | AstraZeneca Pharmaceuticals LP;1800 Concord Pike, P. O. Box 8355;Wilmington, Delaware, 19803 |